Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
144M
-
Number of holders
-
96
-
Total 13F shares, excl. options
-
103M
-
Shares change
-
+8.98M
-
Total reported value, excl. options
-
$482M
-
Value change
-
+$37M
-
Put/Call ratio
-
0.1
-
Number of buys
-
56
-
Number of sells
-
-46
-
Price
-
$4.67
Significant Holders of Applied Therapeutics, Inc. - COMMON STOCK (APLT) as of Q2 2024
128 filings reported holding APLT - Applied Therapeutics, Inc. - COMMON STOCK as of Q2 2024.
Applied Therapeutics, Inc. - COMMON STOCK (APLT) has 96 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 103M shares
of 144M outstanding shares and own 71.86% of the company stock.
Largest 10 shareholders include FRANKLIN RESOURCES INC (10.2M shares), VR Adviser, LLC (9.54M shares), PERCEPTIVE ADVISORS LLC (8.01M shares), JANUS HENDERSON GROUP PLC (7.65M shares), BlackRock Inc. (6.57M shares), Propel Bio Management, LLC (6.57M shares), Knoll Capital Management, LLC (5.57M shares), Vestal Point Capital, LP (5.43M shares), VANGUARD GROUP INC (5.32M shares), and MORGAN STANLEY (3.52M shares).
This table shows the top 96 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.